Back to Search Start Over

In vitro Inhibition of HIV-1 by Cyclotide-Enriched Extracts of Viola tricolor .

Authors :
Conzelmann C
Muratspahić E
Tomašević N
Münch J
Gruber CW
Source :
Frontiers in pharmacology [Front Pharmacol] 2022 May 27; Vol. 13, pp. 888961. Date of Electronic Publication: 2022 May 27 (Print Publication: 2022).
Publication Year :
2022

Abstract

Since viral infectious diseases continue to be a global health threat, new antiviral drugs are urgently needed. A unique class of therapeutic compounds are antimicrobial peptides (AMPs). They can be found in humans, bacteria and plants. Plants express a wide variety of such defense peptides as part of their innate immune system to protect from invading pathogens. Cyclotides are non-classical AMPs that share a similar structure. Their unique topology consists of a circular peptide backbone and disulfide bonds. In previous studies they have been attributed to a wide range of biological activities. To identify novel cyclotides with antiviral activity, we established a library of plant extracts largely consisting of cyclotide-rich species and screened them as inhibitors of HIV-1 infection. Subsequent extraction and fractionation revealed four cyclotide-containing subfractions from Viola tricolor with antiviral activity. These subfractions inhibited HIV-1 infection with IC <subscript>50</subscript> values between 0.6 and 11.2 μg/ml, and selectivity indices of up to 8.1. The identification and characterization of antiviral cyclotides and the determination of the antiviral mechanisms may allow to develop novel agents to combat viral infections. Therefore, cyclotides represent a natural source of bioactive molecules with prospects for development as therapeutics.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Conzelmann, Muratspahić, Tomašević, Münch and Gruber.)

Details

Language :
English
ISSN :
1663-9812
Volume :
13
Database :
MEDLINE
Journal :
Frontiers in pharmacology
Publication Type :
Academic Journal
Accession number :
35712712
Full Text :
https://doi.org/10.3389/fphar.2022.888961